Overview

Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the role of AMH in prediction of poor ovarian response as well as the relation between ESR2 (+1730G>A) (rs4986938), FSHR p.Thr307Ala (c.919A>G, rs6165) and FSHR p.Asn680Ser (c.2039A>G, rs6166) SNPs and the poor response in Egyptian women undergoing IVF procedure. Discovering the genetic variants associated with ovarian response is an important step towards individualized pharmacogenetic protocols of ovarian stimulation.
Phase:
Early Phase 1
Details
Lead Sponsor:
Cairo University
Treatments:
Cetrorelix
Chorionic Gonadotropin
Hormones
Menotropins